Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Regimens for Androgenetic Alopecia
NCT02999737Phase 4Unknown
- Sponsor
- Skin Care and Laser Physicians of Beverly Hills
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of autologous platelet-rich plasma in androgenetic alopecia (AGA) (2 arms), sponsored by Skin Care and Laser Physicians of Beverly Hills. Primary endpoint: Percent change in terminal hair counts at 6 months. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02999737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02999737.